{"DataElement":{"publicId":"3440332","version":"1","preferredName":"Neoplasm American Joint Committee on Cancer Clinical Group Stage","preferredDefinition":"Stage group determined from clinical information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for cancer.","longName":"3440204v1.0:3440309v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3440204","version":"1","preferredName":"Neoplasm Clinical Stage Group","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2404687v1.0:2925061v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2404687","version":"1","preferredName":"Neoplasm","preferredDefinition":"(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0094ACAF-11BC-1BCA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-12","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-12","modifiedBy":"ONEDATA","dateModified":"2005-09-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2925061","version":"1","preferredName":"Clinical Stage Grouping","preferredDefinition":"Having to do with the examination and treatment of patients.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25398:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6FD8E36A-281E-6D78-E040-BB89AD43144A","latestVersionIndicator":"Yes","beginDate":"2009-07-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2009-07-29","modifiedBy":"ONEDATA","dateModified":"2009-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1C4AB1-4DBF-EB7B-E040-BB89AD434E76","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for and approved by TCGA per T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3440309","version":"1","preferredName":"American Joint Committee on Cancer Clinical Group Stage","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3440309v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"12","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage 0","valueDescription":"Stage 0","ValueMeaning":{"publicId":"3203154","version":"1","preferredName":"Stage 0","longName":"3203154","preferredDefinition":"Cancer confined to the epithelium without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0","conceptCode":"C28051","definition":"Cancer confined to the epithelium without invasion of the basement membrane.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B867-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6872-177F-E040-BB89AD431745","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage 0a","valueDescription":"Stage 0a","ValueMeaning":{"publicId":"3262280","version":"1","preferredName":"Stage 0a","longName":"3262280","preferredDefinition":"Cancer confined to the epithelium with formation of papillary structures without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0a","conceptCode":"C27964","definition":"Cancer confined to the epithelium with formation of papillary structures without invasion of the basement membrane or noninvasive localized squamous cell carcinoma.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAA19DDD-412D-ACAB-E040-BB89AD437AD0","latestVersionIndicator":"Yes","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-687C-177F-E040-BB89AD431745","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage 0is","valueDescription":"Stage 0is","ValueMeaning":{"publicId":"3262278","version":"1","preferredName":"Stage 0is","longName":"3262278","preferredDefinition":"Cancer confined to the epithelium with formation of a flat surface without invasion of the basement membrane.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0is","conceptCode":"C27965","definition":"Cancer confined to the epithelium with formation of a flat surface without invasion of the basement membrane.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AAA19DDD-4107-ACAB-E040-BB89AD437AD0","latestVersionIndicator":"Yes","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-08-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6886-177F-E040-BB89AD431745","beginDate":"2011-08-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage I","valueDescription":"Stage I","ValueMeaning":{"publicId":"3179338","version":"1","preferredName":"Stage I","longName":"3179338","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage I","conceptCode":"C27966","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F8FD-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6890-177F-E040-BB89AD431745","beginDate":"2003-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IA","valueDescription":"Stage IA","ValueMeaning":{"publicId":"3203155","version":"1","preferredName":"Stage IA","longName":"3203155","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IA is defined as follows: T1, NO, MO. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IA is defined as follows: T1, N0, M0, G1, G2, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA","conceptCode":"C27975","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IA is defined as follows: T1, N0, M0. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IA is defined as follows: T1, N0, M0, G1, GX. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 8th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B895-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-689A-177F-E040-BB89AD431745","beginDate":"2003-04-16","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IA1","valueDescription":"Stage IA1","ValueMeaning":{"publicId":"3225633","version":"1","preferredName":"Stage IA1","longName":"3225633","preferredDefinition":"A stage term referring to invasive cervical and lung cancer.  For cervical cancer, it includes: T1a1, N0, M0.  T1a1: Tumor with stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA1","conceptCode":"C27983","definition":"A stage term referring to invasive cervical and lung cancer.  For cervical cancer, it includes: T1a1, N0, M0.  T1a1: Tumor with stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: (T1mi, N0, M0); (T1a, N0, M0). T1mi: Minimally invasive adenocarcinoma: adenocarcinoma (3 cm or less in greatest dimension) with a predominantly lepidic pattern and 5 mm or less invasion in greatest dimension. T1a: Tumor measuring 1 cm or less in greatest dimension. A superficial, spreading tumor of any size whose invasive component is limited to the bronchial wall and may extend proximal to the main bronchus also is classified as T1a, but these tumors are uncommon. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-4466-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"COOPERM","dateModified":"2018-07-02","changeDescription":"Updated definition with current NCIt to include criteria with Lung. 7.2.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68A4-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IA2","valueDescription":"Stage IA2","ValueMeaning":{"publicId":"3225632","version":"1","preferredName":"Stage IA2","longName":"3225632","preferredDefinition":"A stage term referring to invasive cervical cancer and invasive lung cancer. For cervical cancer, it includes: T1a2, N0, M0.  T1a2: Tumor with stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA2","conceptCode":"C27984","definition":"A stage term referring to invasive cervical cancer and invasive lung cancer. For cervical cancer, it includes: T1a2, N0, M0.  T1a2: Tumor with stromal invasion more than 3.0 mm and not more than 5.0 mm with a horizontal spread 7.0 mm or less.  N0: No regional lymph node metastasis. M0: No distant metastasis. For lung cancer, it includes: T1b, N0, M0. T1b: Tumor measuring more than 1 cm but 2 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. (adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-4441-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"COOPERM","dateModified":"2018-07-02","changeDescription":"Updated definition to include criteria for lung per NCIt. 7.2.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68AE-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IB","valueDescription":"Stage IB","ValueMeaning":{"publicId":"3203156","version":"1","preferredName":"Stage IB","longName":"3203156","preferredDefinition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IB is defined as follows: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IB is defined as follows: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB","conceptCode":"C27976","definition":"Invasive cancer confined to the original anatomic site of growth without lymph node involvement.  The definition of stage IB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IB is defined as follows: (T0, N1mi, M0); (T1, N1mi, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. N1mi: Nodal micrometastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IB is defined as follows: (T2, N0, M0, G1, G2, GX); (T3, N0, M0, G1, G2, GX). T2: Tumor more than 8 cm in greatest dimension. T3: Discontinuous tumors in the primary bone site. N0: No regional lymph node metastasis. M0: No distant metastasis. G1: Well differentiated-low grade. G2: Moderately differentiated-low grade. GX: Grade cannot be assessed. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B8B8-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68B8-177F-E040-BB89AD431745","beginDate":"2003-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IB Cervix","valueDescription":"Stage IB Cervix","ValueMeaning":{"publicId":"3225631","version":"1","preferredName":"Stage IB Cervix","longName":"3225631","preferredDefinition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: IB (T1b, N0, M0); IB1(T1b1, N0, M0); IB2 (T1b2, N0, M0). T1b: Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a/IA2. T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Cervix","conceptCode":"C96240","definition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: IB (T1b, N0, M0); IB1 (T1b1, N0, M0); IB2 (T1b2, N0, M0). (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-441C-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68C2-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IB1","valueDescription":"Stage IB1","ValueMeaning":{"publicId":"3225630","version":"1","preferredName":"Stage IB1","longName":"3225630","preferredDefinition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b1, N0, M0.  T1b1: Clinically visible lesion 4.0 cm or less in greatest dimension. N0: No regional lymph node metastasis.  M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB1","conceptCode":"C28052","definition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b1, N0, M0. (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-43F7-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68CC-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IB2","valueDescription":"Stage IB2","ValueMeaning":{"publicId":"3225629","version":"1","preferredName":"Stage IB2","longName":"3225629","preferredDefinition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b2, N0, M0.  T1b2: Clinically visible lesion more than 4.0 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB2","conceptCode":"C28053","definition":"A stage term referring to invasive cervical cancer that is confined to the cervix without lymph node involvement.  It includes: T1b2, N0, M0.  (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-43D2-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68D6-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage II","valueDescription":"Stage II","ValueMeaning":{"publicId":"3203157","version":"1","preferredName":"Stage II","longName":"3203157","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II","conceptCode":"C28054","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B8DB-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68E0-177F-E040-BB89AD431745","beginDate":"2003-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage II Cervix","valueDescription":"Stage II Cervix","ValueMeaning":{"publicId":"3225628","version":"1","preferredName":"Stage II Cervix","longName":"3225628","preferredDefinition":"A stage term referring to cervical cancer invading beyond uterus but not to pelvic wall or to lower third of vagina, without lymph node involvement or distant metastasis. Parametrial invasion may or may not be present.  It includes: IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage II Cervix","conceptCode":"C96241","definition":"A stage term referring to cervical cancer invading beyond uterus but not to pelvic wall or to lower third of vagina, without lymph node involvement or distant metastasis. Parametrial invasion may or may not be present.  It includes: IIA (T2a, N0, M0); IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0); IIB (T2b, N0, M0); T2: Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina. T2a: Tumor without parametrial invasion.  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  T2b: Tumor with parametrial invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-43AD-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68EA-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIA","valueDescription":"Stage IIA","ValueMeaning":{"publicId":"3203158","version":"1","preferredName":"Stage IIA","longName":"3203158","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIA is defined as follows: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIA is defined as follows: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA","conceptCode":"C27967","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIA is defined as follows: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIA is defined as follows: T1, N0, M0, G3, G4. T1: Tumor 8 cm or less in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B8FE-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68F4-177F-E040-BB89AD431745","beginDate":"2002-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIA Cervix","valueDescription":"Stage IIA Cervix","ValueMeaning":{"publicId":"3225627","version":"1","preferredName":"Stage IIA Cervix","longName":"3225627","preferredDefinition":"A stage term referring to cervical cancer invading beyond uterus but not to pelvic wall or to lower third of vagina, without lymph node involvement or distant metastasis.  There is no parametrial invasion. It includes: IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0).  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Cervix","conceptCode":"C96242","definition":"A stage term referring to cervical cancer invading beyond uterus but not to pelvic wall or to lower third of vagina, without lymph node involvement or distant metastasis.  There is no parametrial invasion. It includes: IIA1 (T2a1, N0, M0); IIA2 (T2a2, N0, M0).  T2a1: Clinically visible lesion 4.0 cm or less in greatest dimension.  T2a2: Clinically visible lesion more than 4.0 cm in greatest dimension.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (partially adapted from AJCC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A031E3D4-4388-D527-E040-BB89AD43393F","latestVersionIndicator":"Yes","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-68FE-177F-E040-BB89AD431745","beginDate":"2011-04-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIB","valueDescription":"Stage IIB","ValueMeaning":{"publicId":"3203159","version":"1","preferredName":"Stage IIB","longName":"3203159","preferredDefinition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIB is defined as follows: (T2, N1, MO); (T3, NO, MO). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIB is defined as follows: T2, N0, M0, G3 , G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB","conceptCode":"C27968","definition":"Invasive cancer more extensive than stage I, usually involving local lymph nodes without spread to distant anatomic sites.  The definition of stage IIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIB is defined as follows: (T2, N1, MO); (T3, NO, MO). T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N0: No regional lymph node metastasis. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for bone cancer, stage IIB is defined as follows: T2, N0, M0, G3, G4. T2: Tumor more than 8 cm in greatest dimension. N0: No regional lymph node metastasis. M0: No distant metastasis. G3: Poorly differentiated. G4: Undifferentiated. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B921-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6908-177F-E040-BB89AD431745","beginDate":"2002-08-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIC","valueDescription":"Stage IIC","ValueMeaning":{"publicId":"3179327","version":"1","preferredName":"Stage IIC","longName":"3179327","preferredDefinition":"A cancer stage generally indicating the invasion of adjacent structures by cancer without distant metastases.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIC","conceptCode":"C27969","definition":"A cancer stage generally indicating the invasion of adjacent structures by cancer without distant metastases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"98906CB0-F755-EAA3-E040-BB89AD433105","latestVersionIndicator":"Yes","beginDate":"2010-12-29","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6912-177F-E040-BB89AD431745","beginDate":"2007-11-26","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage III","valueDescription":"Stage III","ValueMeaning":{"publicId":"3203160","version":"1","preferredName":"Stage III","longName":"3203160","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage III","conceptCode":"C27970","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B94F-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-691C-177F-E040-BB89AD431745","beginDate":"2003-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIIA","valueDescription":"Stage IIIA","ValueMeaning":{"publicId":"3203161","version":"1","preferredName":"Stage IIIA","longName":"3203161","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.\r\nThe definition of stage IIIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIA is defined as follows: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIA is defined as follows: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA","conceptCode":"C27977","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites. The definition of stage IIIA depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIA is defined as follows: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0). T0: No evidence of primary tumor. T1: Tumor 20 mm or less in greatest dimension. T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension. T3: Tumor more than 50 mm in greatest dimension. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIA is defined as follows: T3a, N0, M0. T3a: Tumor involves lower third of vagina, no extension to pelvic wall. N0: No regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B972-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6926-177F-E040-BB89AD431745","beginDate":"2003-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIIB","valueDescription":"Stage IIIB","ValueMeaning":{"publicId":"3203162","version":"1","preferredName":"Stage IIIB","longName":"3203162","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIB is defined as follows: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIB is defined as follows: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB","conceptCode":"C27978","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIB depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIB is defined as follows: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules). N0: No regional lymph node metastasis. N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s). N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for cervical cancer, stage IIIB is defined as follows: (T3b, Any N, M0); (T1-3, N1, M0). T3: Tumor extends to pelvic wall and/or involves lower third of vagina, and/or causes hydronephrosis or non-functioning kidney. T3b: Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney. N1: Regional lymph node metastasis. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B995-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6930-177F-E040-BB89AD431745","beginDate":"2003-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IIIC","valueDescription":"Stage IIIC","ValueMeaning":{"publicId":"3203163","version":"1","preferredName":"Stage IIIC","longName":"3203163","preferredDefinition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC","conceptCode":"C27982","definition":"Locally advanced cancer that has spread to nearby organs but not to distant anatomic sites.  The definition of stage IIIC depends on the particular type of cancer that it refers to; for example, for breast cancer, stage IIIC is defined as follows: Any T, N3, M0. N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. M0: No clinical or radiographic evidence of distant metastasis. M0 includes M0(i+); for appendix carcinoma, stage IIIC is defined as follows: Any T, N2, M0. N2: Metastasis in four or more regional lymph nodes. M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9B8-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-693A-177F-E040-BB89AD431745","beginDate":"2003-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IV","valueDescription":"Stage IV","ValueMeaning":{"publicId":"3203164","version":"1","preferredName":"Stage IV","longName":"3203164","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV","conceptCode":"C27971","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9DB-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6944-177F-E040-BB89AD431745","beginDate":"2003-04-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IVA","valueDescription":"Stage IVA","ValueMeaning":{"publicId":"3203165","version":"1","preferredName":"Stage IVA","longName":"3203165","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVA depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVA is defined as follows: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung; for vaginal cancer, stage IVA is defined as follows: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVA","conceptCode":"C27979","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVA depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVA is defined as follows: Any T, N0, M1a, Any G. N0: No regional lymph node metastasis. M1a: Distant metastasis to lung; for vaginal cancer, stage IVA is defined as follows: T4, Any N, M0. T4: Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). M0: No distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B9FE-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-694E-177F-E040-BB89AD431745","beginDate":"2003-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IVB","valueDescription":"Stage IVB","ValueMeaning":{"publicId":"3203166","version":"1","preferredName":"Stage IVB","longName":"3203166","preferredDefinition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows:  Any T, Any N, M1. M1: Distant metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVB","conceptCode":"C27980","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVB depends on the particular type of cancer that it refers to; for example, for bone cancer, stage IVB is defined as follows: (Any T, N1, Any M, Any G); (Any T, Any N, M1b, Any G). N1: Regional lymph node metastasis. M1b: Metastasis to other distant sites; for vaginal cancer, stage IVB is defined as follows: Any T, Any N, M1. M1: Distant metastasis. (partially adapted from AJCC 7th ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-BA21-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"ONEDATA","dateModified":"2011-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6958-177F-E040-BB89AD431745","beginDate":"2003-04-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IVC","valueDescription":"Stage IVC","ValueMeaning":{"publicId":"3248483","version":"1","preferredName":"Stage IVC","longName":"3248483","preferredDefinition":"Cancer that has spread to distant anatomic sites beyound its original site of growth.  The definition of stage IVC depends on the particular type of cancer that it refers to; for example, for head and neck carcinomas (lip and oral cavity carcinoma, laryngeal carcinoma, nasal cavity and paranasal sinus carcinoma, pharynx carcinoma, thyroid gland carcinoma, and mjor salivery gland carcinoma) and head and neck mucosal melanoma, stage IVC is defined as follows: any T, any N, M1; for appendix carcinoma, stage IVC is defined as follow: any T, any N, M1b, any G. M1: Distant metastasis. M1b: Nonperitoneal metastasis. G: Grade (celllar differentiation).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IVC","conceptCode":"C28055","definition":"Cancer that has spread to distant anatomic sites beyond its original site of growth. The definition of stage IVC depends on the particular type of cancer that it refers to; for example, for head and neck carcinomas (lip and oral cavity carcinoma, laryngeal carcinoma, nasal cavity and paranasal sinus carcinoma, pharynx carcinoma, thyroid gland carcinoma, and major salivary gland carcinoma) and head and neck mucosal melanoma, stage IVC is defined as follows: any T, any N, M1; for appendix carcinoma, stage IVC is defined as follows: any T, any N, M1b, any G. M1: Distant metastasis.  M1b: Nonperitoneal metastasis.  G: Grade (cellular differentiation).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6B8531E-166A-F891-E040-BB89AD4324F8","latestVersionIndicator":"Yes","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-27","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6962-177F-E040-BB89AD431745","beginDate":"2011-06-27","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage Tis","valueDescription":"Tis Stage Finding","ValueMeaning":{"publicId":"3201442","version":"1","preferredName":"Breast Cancer pTis TNM Finding v6 and v7","longName":"3201442v1.00","preferredDefinition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis TNM Finding v6 and v7","conceptCode":"C48974","definition":"Breast cancer with a finding of carcinoma in situ. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3EC4-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"MMADDINENI","dateModified":"2023-06-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-696C-177F-E040-BB89AD431745","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage X","valueDescription":"Stage X","ValueMeaning":{"publicId":"3203153","version":"1","preferredName":"Stage X","longName":"3203153","preferredDefinition":"A stage term that is applied to patients who have not been evaluated, but are presumed to have cancer.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage X","conceptCode":"C95957","definition":"A stage term that is applied to patients who have not been evaluated, but are presumed to have cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E750F66-B830-C16C-E040-BB89AD4352EB","latestVersionIndicator":"Yes","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-14","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BE1E2E88-6976-177F-E040-BB89AD431745","beginDate":"2011-03-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","deletedIndicator":"No"},{"value":"Stage IS","valueDescription":"Stage Is","ValueMeaning":{"publicId":"4339265","version":"1","preferredName":"Stage Is","longName":"4339265","preferredDefinition":"Testicular cancer found in the testicle, spermatic cord and scrotum, associated with slightly elevated levels of all tumor markers or moderately/highly elevated levels of one or more tumor markers.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IS","conceptCode":"C28285","definition":"Testicular cancer found in the testicle, spermatic cord and scrotum, associated with slightly elevated levels of all tumor markers or moderately/highly elevated levels of one or more tumor markers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA223A1-4601-E4F0-E040-BB89AD436356","latestVersionIndicator":"Yes","beginDate":"2014-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-05-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FAA223A1-462F-E4F0-E040-BB89AD436356","beginDate":"2014-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-05-30","modifiedBy":"ONEDATA","dateModified":"2014-05-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3440308","version":"1","preferredName":"American Joint Committee on Cancer Clinical Stage Grouping Stage","preferredDefinition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C39315:C25398:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1E2E88-6849-177F-E040-BB89AD431745","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"ONEDATA","dateModified":"2012-04-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1E2E88-685A-177F-E040-BB89AD431745","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"COOPERM","dateModified":"2014-05-30","changeDescription":"Created for and approved by TCGA per T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"},{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"},{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787514","version":"1","longName":"OV","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"}]},{"publicId":"5506115","version":"1","longName":"Imaging","context":"MCL","ClassificationSchemeItems":[{"publicId":"5983666","version":"1","longName":"Vanderbilt Image Archive","context":"MCL"}]},{"publicId":"5506116","version":"1","longName":"Pathology","context":"MCL","ClassificationSchemeItems":[{"publicId":"5855641","version":"1","longName":"Lung Pathology","context":"MCL"}]}],"AlternateNames":[{"name":"clinical_stage","type":"TCGA_XML_Name","context":"NCIP"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"NEOP_CLIN_AJCC_GRP_STG","type":"COG GDE Short Name","context":"COG"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"DS_STG_TY","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"Clinical Stage","type":"Preferred Question Text","description":"Clinical Stage","url":null,"context":"NCIP"},{"name":"Generic TCGA CDE","type":"NOTE","description":"This generic element includes stage group values from multiple editions of AJCC as provided by The Cancer Genome Atlas (TCGA).","url":null,"context":"NCIP"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"AJCC STAGE","url":null,"context":"COG"},{"name":"MCL-PCA-1","type":"Alternate Question Text","description":"Clinical Stage","url":null,"context":"MCL"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BE1E2E88-6A46-177F-E040-BB89AD431745","latestVersionIndicator":"Yes","beginDate":"2012-04-20","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-04-20","modifiedBy":"KUMMEROA","dateModified":"2023-11-16","changeDescription":"10/4/21 mr Removed MCL Lung PCA classification. Per MCL DD.   Created and released for TCGA per approval by T.Lichtenberg. mc 4/23/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}